A human SARS-CoV neutralizing antibody against epitope on S2 protein.
An immune antibody phage-display library was constructed from B cells of SARS convalescent patients. More than 80 clones were selected from the library by using the whole inactivated SARS-CoV virions as target. One human scFv, B1, was characterized extensively. The B1 recognized SARS pseudovirus in vivo and competed with SARS sera for binding to SARS-CoV with high affinity (equilibrium dissociation constant, K(d) = 105 nM). The B1 also has potent neutralizing activities against infection by pseudovirus expressing SARS-CoV S protein in vitro. Finally, we found that the B1 recognized an epitope on S2 protein, especially within amino acids 1023-1189 of S2 protein. This study not only first made a human neutralizing antibody, which recognized an epitope on S2 protein like natural antibody in sera, but also may help us to better understand the immunological characteristics of SARS protein and SARS vaccine design.
Duan
Jinzhu
J
State Key Laboratory of Microbial Resources, Institute of Microbiology, Beijing, China.
Yan
Xiyun
X
Guo
Xueming
X
Cao
Wuchun
W
Han
Wei
W
Qi
Cai
C
Feng
Jing
J
Yang
Dongling
D
Gao
Guangxia
G
Jin
Gang
G
D000906:Antibodies / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology; D018604:Epitope Mapping / Q000379:methods*; D018985:Epitopes, B-Lymphocyte / Q000276:immunology*; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D009500:Neutralization Tests / Q000379:methods; D019151:Peptide Library; D045473:Severe acute respiratory syndrome-related coronavirus / Q000276:immunology*; D014759:Viral Envelope Proteins / Q000276:immunology*
D000906:Antibodies; D018985:Epitopes, B-Lymphocyte; D019151:Peptide Library; D014759:Viral Envelope Proteins